AbbVie Inc 2024 SR
The report highlights AbbVie's 2024 progress across its ESG framework, focusing on patient-first innovation, human-focused progress, and maintaining a resilient business. Key achievements include a 32.4% reduction in absolute Scope 1 and 2 greenhouse gas emissions since 2021 and reaching 60.4% renewable electricity sourcing. The company invested $10.8 billion in adjusted R&D, resulting in nine product or indication approvals. Socially, AbbVie provided free medicines to over 235,000 U.S. patients through its assistance programs and raised $25 million for nonprofits via employee donations. Additionally, the company completed a double materiality assessment to align with future mandatory disclosure requirements.
Company: AbbVie Inc
Sector: Information Information Technology
Country: United States
Year: 2024
Type: SR
Pages: 54
AbbVie Inc
ESG Action Report
The report highlights AbbVie's 2024 progress across its ESG framework, focusing on patient-first innovation, human-focused progress, and maintaining a resilient business. Key achievements include a 32.4% reduction in absolute Scope 1 and 2 greenhouse gas emissions since 2021 and reaching 60.4% renewable electricity sourcing. The company invested $10.8 billion in adjusted R&D, resulting in nine product or indication approvals. Socially, AbbVie provided free medicines to over 235,000 U.S. patients through its assistance programs and raised $25 million for nonprofits via employee donations. Additionally, the company completed a double materiality assessment to align with future mandatory disclosure requirements.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees